Free Trial

Nautilus Biotechnology (NAUT) SEC Filings & 10K Form

Nautilus Biotechnology logo
$0.82 +0.04 (+4.98%)
As of 07/3/2025 02:21 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Recent Nautilus Biotechnology SEC Filings

DateFilerForm TypeView
06/25/2025
3:36 PM
Akinsanya Karen (Reporting)
Nautilus Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2025
3:37 PM
Nautilus Biotechnology (Issuer)
NAZEM FARZAD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2025
3:37 PM
McIlwain Matthew S (Reporting)
Nautilus Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2025
3:37 PM
Nautilus Biotechnology (Issuer)
Posard Matthew L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2025
3:37 PM
Epperly Melissa B, (Reporting)
Nautilus Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2025
3:34 PM
Nautilus Biotechnology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/02/2025
4:12 PM
Mowry Anna (Reporting)
Nautilus Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/12/2025
6:19 PM
Mallick Parag (Reporting)
Nautilus Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2025
3:30 PM
Nautilus Biotechnology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/21/2025
3:44 PM
Nautilus Biotechnology (Issuer)
Patel Sujal M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2025
3:52 PM
Nautilus Biotechnology (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
01/31/2025
8:06 PM
Nautilus Biotechnology (Subject)
PERCEPTIVE ADVISORS LLC (Filed by)
Form SCHEDULE 13D/A
01/31/2025
4:15 PM
Nautilus Biotechnology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/17/2024
4:21 PM
Godwin Mary E. (Reporting)
Nautilus Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/09/2024
3:28 PM
Godwin Mary E. (Reporting)
Nautilus Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/03/2024
3:28 PM
Godwin Mary E. (Reporting)
Nautilus Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/26/2024
3:31 PM
Godwin Mary E. (Reporting)
Nautilus Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/21/2024
4:28 PM
Godwin Mary E. (Reporting)
Nautilus Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/12/2024
10:38 AM
Godwin Mary E. (Reporting)
Nautilus Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/07/2024
3:25 PM
Godwin Mary E. (Reporting)
Nautilus Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/25/2024
5:29 PM
Godwin Mary E. (Reporting)
Nautilus Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/23/2024
3:58 PM
Godwin Mary E. (Reporting)
Nautilus Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/18/2024
5:32 PM
Godwin Mary E. (Reporting)
Nautilus Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2024
3:40 PM
Nautilus Biotechnology (Issuer)
Suzuki Kentaro (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/17/2024
3:47 PM
Nautilus Biotechnology (Issuer)
Suzuki Kentaro (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2024
3:22 PM
Godwin Mary E. (Reporting)
Nautilus Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:NAUT) was last updated on 7/5/2025 by MarketBeat.com Staff
From Our Partners